Wednesday, July 31, 2013

NYT > Health: Merck Profit Plunges 50% as Generics Cut Into Sales

Merck Profit Plunges 50% as Generics Cut Into Sales

This year the company has been hurt by plunging sales for Singulair, Maxalt, Propecia and Clarinex.

Source: http://www.nytimes.com/2013/07/31/business/merck-profit-plunges-as-generics-take-market-share.html?partner=rss&emc=rss


No comments:

Post a Comment

Subscribe Now: Feed Icon